Skip to main content
Log in

Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferi

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The in vitro and in vivo activity of the new macrolides azithromycin, clarithromycin and roxythromycin was compared with that of erythromycin againstBorrelia burgdorferi. In in vitro tests using ten clinical isolates all macrolides were highly active againstBorrelia burgdorferi (MIC90 0.015–0.06 µg/ml). Azithromycin was more potent than the other macrolides in experimental animal infection, eradicating the organism in all animals tested at a dosage of 8 mg/kg.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Steere, A. C., Pachner, A. R., Malawista, S. E. Neurological abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Annals of Internal Medicine 1983, 99: 767–772.

    PubMed  Google Scholar 

  2. Weber, K. Treatment of Lyme disease. Annals of Internal Medicine 1981, 94: 137.

    Google Scholar 

  3. Preac-Mursic, V., Wilske, B., Schierz, G., Holnburger, M., Süß, E. In vitro and in vivo susceptibility ofBorrelia burgdorferi. European Journal of Clinical Microbiology 1987, 4: 424–426.

    Google Scholar 

  4. Johnson, R. C., Kodner, C., Russel, M. In vitro and in vivo susceptibility of the Lyme disease spirochete,Borrelia burgdorferi, to four Antimicrobial Agents. Antimicrobial Agents and Chemotherapy 1987, 31: 164–167.

    PubMed  Google Scholar 

  5. Preac-Mursic, V., Wilske, B., Schierz, G. EuropeanBorrelia burgdorferi isolated from humans and ticks — culture conditions and antibiotic susceptibility. Zentralblatt für Bakteriologic, Mikrobiologie und Hygiene (A) 1986, 263: 112–118.

    Google Scholar 

  6. Wilske, B., Schierz, G., Preac-Mursic, V., Weber, K., Pfister, H. W., Einhäupl, K. Serological diagnosis of erythema migrans disease and related disorders. Infection 1984, 12: 331–337.

    PubMed  Google Scholar 

  7. Dette, G. A., Knothe, H., Koulen, G. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, Ru 28965, erythromycin and josamycin. Drugs under Experimental and Clinical Research 1987, 13: 567–576.

    PubMed  Google Scholar 

  8. Dwight, J. H., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J., Fernandes, P.B. Comparative in vitro activities of new 14-, 15- and 16-membered macrolides. Antimicrobial agents and Chemotherapy 1988, 11: 1710–1719.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preac-Mursic, V., Wilske, B., Schierz, G. et al. Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferi . Eur. J. Clin. Microbiol. Infect. Dis. 8, 651–653 (1989). https://doi.org/10.1007/BF01968150

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01968150

Keywords

Navigation